STOCK TITAN

Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) Chairman and Chief Executive Officer Irwin D. Simon will participate in a fireside chat at the Bernstein 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, in New York City beginning at 11:00 am Eastern Time. The fireside chat will be hosted by Nadine Sarwat, Director & Analyst, European & American Alcoholic Beverages, North America Cannabis.  

Tilray’s Chief Financial Officer Carl Merton will also be meeting with institutional investors throughout the day. Please contact your Bernstein representative to schedule a meeting.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing products that meet the needs of mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for patients and consumers by providing a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform now supports over 20 brands in over 20 countries, including a comprehensive portfolio of medical cannabis, adult-use cannabis, wellness products and hemp-based foods, and alcoholic beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

For further information:

Media: Berrin Noorata, news@tilray.com

Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com

 


Tilray Brands Inc

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Process Industries, Agricultural Commodities/Milling, Manufacturing, Medicinal and Botanical Manufacturing
Canada
Nanaimo

About TLRY

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.